Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: Intervention group : Patients use 2 tablets of prednisolone 5 mg (Iran Hormone Company) and one tablet of Verogest 2 mg (Ati Pharmed Company) daily for up to 3 months continuously. Int
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: confirm with trans vaginal / trans rectal ultra sonography candidate for medical therapy At least one year after surgical treatment 18 to 45 years no desire to get pregnant in the last 3 months
Exclusion criteria
Exclusion criteria: Oligomenorrhea for three months or more Primary need for endometriosis surgical treatment Use of other hormonal agents during the study period Abnormal findings in women's examination except endometriosis Endometrioma above 5 cm Contraindications for glucocorticoid use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dyspareunia. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dysmenorrhea. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dyschezia. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhaneh Hosseini
Tehran University of Medical Sciences
Outcome results
None listed